Author Title Type [ Year(Asc)]
Filters: First Letter Of Title is C  [Clear All Filters]
Seidel, H.S., Smith, T.A., Evans, J.K., Stamper, J.Q., Mast, T.G., and Kimble, J. (2018). C. elegans germ cells divide and differentiate in a folded tissue.Dev Biol.
Taheri, B., Soleimani, M., Aval, S.Fekri, Memari, F., and Zarghami, N. (2018). C6 glioma-derived microvesicles stimulate the proliferative and metastatic gene expression of normal astrocytes.Neurosci Lett.
Lee, S., Kim, S., Park, Y.Joo, Yun, S.Pil, Kwon, S.-H., Kim, D., Kim, D.Yeon, Shin, J.Soo, Cho, D.Jin, Lee, G.Yeal, et al. (2018). The c-Abl inhibitor, Radotinib HCl is neuroprotective in a preclinical Parkinson's disease mouse model.Hum Mol Genet.
Zhang, F., Ye, J., Meng, Y., Ai, W., Su, H., Zheng, J., Liu, F., Zhu, X., Wang, L., Gao, P., et al. (2018). Calcium Supplementation Enhanced Adipogenesis and Improved Glucose Homeostasis Through Activation of Camkii and PI3K/Akt Signaling Pathway in Porcine Bone Marrow Mesenchymal Stem Cells (pBMSCs) and Mice Fed High Fat Diet (HFD).Cell Physiol Biochem51, 154-172.
Thomas, N.J., Spear, D., Wasserman, E., Pon, S., Markovitz, B., Singh, A.R., Li, S., Gertz, S.J., Rowan, C.M., Kunselman, A., et al. (2018). CALIPSO: A RANDOMIZED CONTROLLED TRIAL OF CALFACTANT FOR ACUTE LUNG INJURY IN PEDIATRIC STEM CELL AND ONCOLOGY PATIENTS.Biol Blood Marrow Transplant.
Ma, Z., Parris, A.B., Howard, E.W., Shi, Y., Yang, S., Jiang, Y., Kong, L., and Yang, X. (2018). Caloric restriction inhibits mammary tumorigenesis in MMTV-ErbB2 transgenic mice through the suppression of ER and ErbB2 pathways and inhibition of epithelial cell stemness in premalignant mammary tissues.Carcinogenesis.
Saitta, B., Elphingstone, J., Limfat, S., Shkhyan, R., and Evseenko, D. (2018). CaMKII Inhibition in Human Primary and Pluripotent Stem Cell-Derived Chondrocytes Modulates effects of TGFβ and BMP Through SMAD Signaling.Osteoarthritis Cartilage.
Chen, Y.-C., Chang, Y.-W., Tan, K.Poay, Shen, Y.-S., Wang, Y.-H., and Chang, C.-H. (2018). Can mesenchymal stem cells and their conditioned medium assist inflammatory chondrocytes recovery?.Plos One13, e0205563.
Solmaz, S., Acar, C., Olgun, A., Acar, A., Seyhanlı, A., Taskıran, E., Sevindik, Ö.Gökmen, Alacacıoğlu, İ., Pişkin, Ö., Özcan, M.Ali, et al. (2018). Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?.Clin Transplante13359.
Savoie, M.Lynn, Bence-Bruckler, I., Huebsch, L.B., Lalancette, M., Hillis, C., Walker, I., Lipton, J.H., Forrest, D.L., and Kim, D.Dong Hwan (2018). Canadian chronic myeloid leukemia outcomes post-transplant in the tyrosine kinase inhibitor era.Leuk Res73, 67-75.
da Silva-Diz, V., Lorenzo-Sanz, L., Bernat-Peguera, A., Lopez-Cerda, M., and Muñoz, P. (2018). Cancer cell plasticity: Impact on tumor progression and therapy response.Semin Cancer Biol.
Ratajczak, M.Z., Bujko, K., Mack, A., Kucia, M., and Ratajczak, J. (2018). Cancer from the perspective of stem cells and misappropriated tissue regeneration mechanisms.Leukemia.
Samadani, A.Akbar, Norollahi, S.Elham, Rashidy-Pour, A., Mansour-Ghanaei, F., Nemati, S., Joukar, F., Afshar, A.Mahmoud, Ghazanfari, S., Safizadeh, M., Rostami, P., et al. (2018). Cancer signaling pathways with a therapeutic approach: An overview in epigenetic regulations of cancer stem cells.Biomed Pharmacother108, 590-599.
Zheng, F., Dang, J., Zhang, H., Xu, F., Ba, D., Zhang, B., Cheng, F., Chang, A.E., Wicha, M.S., and Li, Q. (2018). Cancer Stem Cell Vaccination With PD-L1 and CTLA-4 Blockades Enhances the Eradication of Melanoma Stem Cells in a Mouse Tumor Model.J Immunother.
Aghaalikhani, N., Rashtchizadeh, N., Shadpour, P., Allameh, A., and Mahmoodi, M. (2018). Cancer stem cells as a therapeutic target in bladder cancer.J Cell Physiol.
Harada, K., Pizzi, M.Pool, Baba, H., Shanbhag, N.D., Song, S., and Ajani, J.A. (2018). Cancer stem cells in esophageal cancer and response to therapy.Cancer.
Miyoshi, N., Mizushima, T., Doki, Y., and Mori, M. (2018). Cancer stem cells in relation to treatment.Jpn J Clin Oncol.
Makena, M.Ram, Ranjan, A., Thirumala, V., and Reddy, A. (2018). Cancer stem cells: Road to therapeutic resistance and strategies to overcome resistance.Biochim Biophys Acta Mol Basis Dis.
Dianat-Moghadam, H., Heydarifard, M., Jahanban-Esfahlan, R., Panahi, Y., Hamishehkar, H., Pouremamali, F., Rahbarghazi, R., and Nouri, M. (2018). Cancer stem cells-emanated therapy resistance: Implications for liposomal drug delivery systems.J Control Release.
Rahane, C.Satish, Kutzner, A., and Heese, K. (2018). A cancer tissue-specific FAM72 expression profile defines a novel glioblastoma multiform (GBM) gene-mutation signature.J Neurooncol.
Gordeeva, O. (2018). Cancer-testis antigens: unique cancer stem cell biomarkers and targets for cancer therapy.Semin Cancer Biol.
Xie, C., Xu, M., Lu, D., Zhang, W., Wang, L., Wang, H., Li, J., Ren, F., and Wang, C. (2018). Candidate genes and microRNAs for glioma pathogenesis and prognosis based on gene expression profiles.Mol Med Rep.
Sullivan, S.E., Liao, M., Smith, R.V., White, C., Lagomarsino, V.N., Xu, J., Taga, M., Bennett, D.A., De Jager, P.L., and Young-Pearse, T.L. (2018). Candidate-based screening via gene modulation in human neurons and astrocytes implicates FERMT2 in Aβ and TAU proteostasis.Hum Mol Genet.